A dark gray mass 3 cm in diameter replacing the right frontal cortex was found in the brain of a 5-year-old male Doberman Pinscher dog at necropsy. Microscopic studies revealed that the mass consisted of a proliferation of pleomorphic tumor cells: large bizarre or plump eosinophilic cells, multinucleated giant cells, and small lymphocytic cells. These neoplastic cells at the margin of the necrotic area had a psuedopalisade arrangement and tended to proliferate around blood vessels. Immunohistochemically, the tumor cells reacted intensely with the antibody for vimentin and moderately with those for S-100 and glial fibrillary acidic protein. This canine tumor is placed in the category of glioblastoma or undifferentiated astrocytoma, which is analogous to human giant cell glioblastoma.
Astrocytomas and glioblastomas are the most common brain tumors in several animal species, especially dogs. These tumors are thought to originate from astrocytes and show various histologic patterns with marked cellular variations.1.3-5.7.8 Astrocytomas and glioblastomas have been distinguished according to histologic f e a t u r e~.~ In contrast, astrocytomas have been lumped with glioblastomas and divided into two subtypes by their degree of malignancy, i.e., differentiated or undifferentiated astrocytomas. The present paper describes an undifferentiated canine astrocytoma (glioblastoma) mimicking human giant cell glioblastoma.
A 5-year-old male Doberman Pinscher dog was brought to a private veterinary hospital in Miyazaki, Japan, 30 August 1993 with epileptiform neurologic signs. These clinical symptoms progressed continuously until the dog died 19 October 1993. At necropsy, there was a dark gray soft mass 3 cm in diameter replacing the right frontal cortex and olfactory bulbus. The mass was easily removed from intact brain tissues and did not invade the nasal cavity. The cut surface of the mass was mottled red and black and was liquefied (Fig. 1) . No significant gross lesions were observed in the other visceral organs.
Samples from the brain mass were fixed with 10% formalin for routine histologic examination and with methanol-Carnoy's solution for immunohistochemical evaluation and were embedded in paraffin. Epoxy-resin-embedded sections were also made for ultrastructural examinations. Immunostaining was performed by the avidin-biotin peroxidase complex method using a system kit (Vectastain PK-4000, Vector Laboratories, Burlingame, CA). As primary antibodies, rabbit sera against keratin (prediluted, Dako, Carpinteria, CA), S-100 protein (1 : 200, Dako), alpha 1 -antitrypsin ( 1 : 200, Dako), cathepsin D (1 : 100, Dako), lysozyme (prediluted, Dako), and myelin basic protein (prediluted, Zymed Laboratories, South San Francisco, CA) and monoclonal antibodies for vimentin (prediluted, Dako), sarcomeric actin (1 : 10, Dako), neurofilament (1 : 20, Dako) of high and low molecular weight, and synaptophisin (4 &ml, Boehringer Mannheim, Germany) were used. In addition, four kinds of antibody against glial fibrillary acidic protein (GFAP) were also used. The source and working dilution of these antibodies for GFAP are shown in Table 1 . For secondary antibodies, biotinylated goat antisera against rabbit or mouse immunoglobulins (1 : 200, Dako) were used. Binding to Ricinus cornrnunis agglutinin-1 (RCA-1, 1 : 400, EY Laboratories, San Mateo, CA), which is known as a marker of microglia, was also examined as described previously.6 The reaction products were visualized with 3,3'-diaminobenzidin, and Mayer's hematoxylin was used as a counterstain.
Microscopic studies revealed that the mass in the right olfactory bulbus and frontal cortex consisted of a pleomorphic population of atypical large cells and necrotic foci. The tumor mass was surrounded by normal brain tissue in the frontal cortex; no infiltration of neoplastic cells was found in any other brain region or visceral organ. The neoplastic cells at the margin of the necrotic area showed a palisadelike arrangement known as a pseudopalisade and tended to proliferate around blood vessels (Fig. 2) . Abnormally large bizarre or plump eosinophilic cells with atypical nuclei, mimicking hypertrophic astrocytes, were a dominant feature. The plump giant cells sometimes contained cytoplasmic pale inclusionlike structures, and multinucleated cells or syncyitium for- mations of tumor cells were also observed frequently (Fig.  3) . In addition, small lymphocytic cells proliferated among these giant or multinucleated cells. Mitotic forms of the neoplastic cells were commonly detected. Aggregates of lymphocytes and plasma cells were occasionally seen around blood vessels. Ultrastructurally, the tumor cells had cytoplasmic filaments and mitochondria, but typical glial filaments were not observed. Immunohistochemically, almost all the neoplastic cells showed intense reactivity for vimentin and about half of them were also positive for S-100. Immunostaining, using a monoclonal antibody for human GFAP (Dako), showed only a few GFAP-positive cells; the anaplastic tumor cells, such as giant cells, did not react with GFAP. In contrast, neoplastic giant cells showed moderate to slight immunoreactivity for rabbit sera against GFAP (Dako, BioMarker, and Zymed), whereas these reactivities were relatively weak as compared with those for vimentin and S-100 ( Table 1 ). Significant immunoreactivities were not The positive reactions to S-100 and GFAP suggest that the canine tumor might have originated from glial cells, but these immunoreactivities were relatively limited compared with that for vimentin. In the present study, four kinds ofantibody against GFAP were examined. Although a monoclonal antibody against human GFAP did not recognize tumor cells, neoplastic giant cells reacted with the other three rabbit antisera. The different immunoreactivities may be due to the but the present tumor consisted predominantly of abnormally large giant cells and multinucleated cells. In a recent report, a brain tumor in a Syrian hamster that had morphologic characteristics similar to the present canine tumor was diagnosed as a giant cell glioblastoma. Although the term giant cell glioblastoma has not been proposed in brain tumors of domestic animals, the present canine tumor seems to belong to the category of glioblastoma or undifferentiated astrocytoma, which is analogous to giant cell gliobla~toma.~
